Fast Treatment of Methamphetamine Related Anxiety and Depressive Disorders: A Novel Approach

Journal of Addiction Medicine and Therapeutic Science
Research Article
Abstract 
Background: Methamphetamine abuse and dependence is currently a considerable problem. Objective: To explain the efficacy of buprenorphine in the quick management of methamphetamine related anxiety and depressive disorders and also methamphetamine withdrawal craving. Results: 52 mg of buprenorphine is very valuable in the treatment of severe methamphetamine related anxiety and depression and also methamphetamine craving. Discussion: This study lightens that high dose of buprenorphine is quite effective in the lowering of anxiety, depression, and chest pain and methamphetamine withdrawal symptoms. Hence, our finding is a substantial addition to the literature. Conclusions: We resulted that a single high dose of buprenorphine could quickly subside methamphetamine induced anxiety, depression, psychogenic pain and withdrawal symptoms. It looks that buprenorphine may be a safe and valuable drug for the treatment of the majority of methamphetamine associated disorders.
http://www.peertechz.com/Addiction-Medicine-Therapeutic-Science/pdf/JAMTS-2-111.pdf

Comments

Popular posts from this blog

Case Report: Reynolds Syndrome

Successful treatment of Budd- Chiari Syndrome with Percutaneous transluminal Balloon Angioplasty

Apparent Digestibility and Utilization of Protein and Phosphorus in diets of incorporated with Sprouted Sorghum, Phytase and Protease Enzymes for African Catfi sh (Clarias gariepinus)